F
Filip K. Knop
Researcher at University of Copenhagen
Publications - 523
Citations - 17834
Filip K. Knop is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 61, co-authored 437 publications receiving 13614 citations. Previous affiliations of Filip K. Knop include Copenhagen University Hospital & Victor Chang Cardiac Research Institute.
Papers
More filters
Journal ArticleDOI
Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study.
Mats Christian Højbjerg Lassen,Kristoffer Grundtvig Skaarup,Jannie Nørgaard Lind,Alia Saed Alhakak,Morten Sengeløv,Anne Bjerg Nielsen,Caroline Espersen,Kirstine Ravnkilde,Raphael Hauser,Liv Borum Schöps,Eva Holt,Niklas Dyrby Johansen,Daniel Modin,Kasper Djernæs,Claus Graff,Henning Bundgaard,Christian Hassager,Reza Jabbari,Jørn Carlsen,Anne-Mette Lebech,Ole Kirk,Uffe Bodtger,Matias Greve Lindholm,Gowsini Joseph,Lothar Wiese,Frank V. Schiødt,Ole Peter Kristiansen,Emil S. Walsted,Olav W. Nielsen,Birgitte Lindegaard Madsen,Niels Tønder,Thomas Benfield,Klaus Nielsen Jeschke,Charlotte Suppli Ulrik,Filip K. Knop,Morten Lamberts,Pradeesh Sivapalan,Gunnar Gislason,Jacob Louis Marott,Rasmus Mogelvang,Gorm Boje Jensen,Peter Schnohr,Peter Søgaard,Scott D. Solomon,Kasper Iversen,Jens-Ulrik Stæhr Jensen,Morten Schou,Tor Biering-Sørensen +47 more
TL;DR: Comparing echocardiographic parameters in COVID‐19 patients with matched controls and assessing the prognostic value of measures of left (LV) and right ventricular (RV) function in relation to CO VID‐19 related death are compared.
Journal ArticleDOI
Species-specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
Alexander Hovard Sparre-Ulrich,L S Hansen,Berit Svendsen,Mikkel Christensen,Filip K. Knop,B. Hartmann,J. J. Holst,Mette M. Rosenkilde +7 more
TL;DR: In this paper, a pharmacological analysis of (Pro3)GIP including interspecies differences between the rodent and human GIP system was conducted, and it was shown that Rodent GIPs are more potent and efficacious at their receptors than humanGIPs.
Journal ArticleDOI
Mechanism of Metabolic Advantages After Bariatric Surgery: It’s all gastrointestinal factors versus it’s all food restriction
Filip K. Knop,Roy Taylor +1 more
TL;DR: It is striking that amelioration of hyperglycemia after bariatric surgery occurs within days of the surgery, pointing to immediate, weight loss–independent mechanisms possibly related to surgery-induced changes in food intake, gastrointestinal (GI) anatomy, or transit of nutrients.
Journal ArticleDOI
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
Kristian Hallundbæk Mikkelsen,Morten Frost,Martin Iain Bahl,Tine Rask Licht,Ulrich S. Jensen,Jacob Rosenberg,Oluf Pedersen,Torben Hansen,Torben Hansen,Jens F. Rehfeld,Jens J. Holst,Tina Vilsbøll,Filip K. Knop +12 more
TL;DR: A broad-spectrum 4-day antibiotics course with vancomycin, gentamycin and meropenem induced shifts in gut microbiota composition that had no clinically relevant short or long-term effects on metabolic variables in healthy glucose-tolerant males.
Journal ArticleDOI
Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.
Morten Bagge Hansen,Matthijs J. Scheltema,Matthijs J. Scheltema,David P. Sonne,Jakob S. Hansen,Michael Sperling,Jens F. Rehfeld,Jens J. Holst,Tina Vilsbøll,Filip K. Knop +9 more
TL;DR: The effects of the primary human bile acid, chenodeoxycholic acid (CDCA), and the bile Acid sequestrant (BAS) colesevelam, instilled into the stomach, on plasma levels of glucagon‐like peptide‐1 (GLP‐1), glucose‐dependent insulinotropic polypeptides, glucose, insulin, C‐peptide, glucagon, cholecystokinin and gastrin are evaluated.